share_log

東瑞製藥:須予披露交易有關非布司他的上市許可持有人

DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION MARKETING AUTHORIZATION HOLDER (MAH) IN RESPECT OF FEBUXOSTAT

Dec 24, 2019 09:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more